Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:07:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:03:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the page body, with a Home link, rather than clinical study details.
    Difference
    0.5%
    Check dated 2026-10-03T14:04:49.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and navigation, hiding the study record details that were previously listed (e.g., title, conditions, inclusion/exclusion criteria, locations, and contacts).
    Difference
    19%
    Check dated 2026-09-19T19:20:58.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays the latest system revision tag (v3.6.6) replacing the previous v3.6.5. This indicates a software update and does not alter the study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:55:36.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small internal update to the page or CMS. No user-visible content changes are expected.
    Difference
    0.1%
    Check dated 2026-08-08T10:45:25.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.